Current issue
Archive
Online first
About the Journal
Editorial Office
Editorial Board
Publisher
Editorial Policies
Ethical standards and procedures
Abstracting and indexing
Reviewers
Honorary Reviewers
Subscription
Contact
Most read articles
Instructions for authors
Article processing charge (APC)
Books and Events
Books
Events
GUIDELINES
Gout and calcium pyrophosphate dihydrate deposition disease
Online publication date: 2016-10-11
Reumatologia 2016;(Aktualizacja zaleceń postępowania diagnostyczno-terapeutycznego w chorobach reumatycznych na podstawie rekomendacji EULAR/ACR 1):105-109
REFERENCES (17)
1.
Murray R, Granner D, Rodwell V. Biochemia Harpera, Wydawnictwo Lekarskie PZWL, Warszawa 2013.
2.
Singh JA. Racial and gender disparities among patients with gout. Curr Rheumatol Rep 2013; 15: 307.
3.
Bardin T, Bouée S, Clerson P, et al. Prevalence of Gout in the Adult Population of France. Arthritis Care Res (Hoboken) 2016; 68: 261-266.
4.
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population. The National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 2011; 63: 3136-3141.
5.
Raciborski F, Maślińska M, Kłak A i wsp. Występowanie i leczenie dny moczanowej w Polsce. Analiza, wskazania, rekomendacje. Instytut Ochrony Zdrowia w Polsce, Warszawa 2015.
6.
Zimmermann-Górska I. Postępowanie diagnostyczno-terapeutyczne w chorobach wywoływanych przez kryształy. Reumatologia 2012; 50: 177-180.
7.
Sivera F, Andrés M, Carmona L, et al. Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis 2014; 73: 328-335.
8.
Tuhina N, Jansen TL, Dalbeth N, et al. Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2015; 74: 1789-1798.
9.
Majdan M: Dna moczanowa – nowe możliwości diagnostyczne i terapeutyczne. Reumatologia 2013; 51: 1-8.
10.
Ward IM, Scott JN, Mansfield LT, Battafarano DF. Dual-Energy Computed Tomography Demonstrating Destructive Calcium Pyrophosphate Deposition Disease of the Distal Radioulnar Joint Mimicking Tophaceous Gout. J Clin Rheumatol 2015; 21: 314-317.
11.
Khanna D, Fitzgerald JD, Khanna PP, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res 2012; 64: 1431-1446.
12.
Ottaviani S, Moltó A, Ea HK, et al. Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases. Arthritis Res Ther 2013; 15: R123.
13.
Grygiel-Górniak B, Puszczewicz MJ. Dieta w dnie moczanowej i hiperurykemii – mity i fakty. Reumatologia 2014; 52: 269-279.
14.
Zhang Y, Neogi T, Chen C, et al. Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum 2012; 64: 4004-4011.
15.
Bridgeman MB, Chavez B. Febuxostat for the treatment of gout. Expert Opin Pharmacother 2015;16: 395-398.
16.
Pascart T, Richette P, Flipo RM. Treatment of nongout joint deposition diseases: an update. Arthritis 2014; 2014: 375202.
17.
Chollet-Janin A, Finckh A, Dudler J, Guerne PA. Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis. Arthritis Rheum 2007; 56: 688-692.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
